MS159 is a First-In-class NSD2 PROTAC degrader for Multiple Myeloma Research
Proteolytic targeting chimera (PROTAC) is a heterobifunctional small molecule, including two active domains, and a linker. Importantly, it can remove specific unwanted proteins. PROTAC is a technology based on the…